Advertisement
Canada markets close in 5 hours 16 minutes

  • S&P/TSX

    21,735.80
    -137.92 (-0.63%)
     

  • S&P 500

    5,005.02
    -66.61 (-1.31%)
     

  • DOW

    37,780.41
    -680.51 (-1.77%)
     

  • CAD/USD

    0.7299
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    82.22
    -0.59 (-0.71%)
     

  • Bitcoin CAD

    86,981.83
    -1,884.26 (-2.12%)
     

  • CMC Crypto 200

    1,379.14
    -3.43 (-0.25%)
     

  • GOLD FUTURES

    2,346.30
    +7.90 (+0.34%)
     

  • RUSSELL 2000

    1,969.54
    -25.89 (-1.30%)
     

  • 10-Yr Bond

    4.7080
    +0.0560 (+1.20%)
     

  • NASDAQ

    15,457.75
    -255.00 (-1.62%)
     

  • VOLATILITY

    16.84
    +0.87 (+5.45%)
     

  • FTSE

    8,065.48
    +25.10 (+0.31%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6807
    -0.0012 (-0.18%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Moderna improves forecast for 2022 sales from COVID-19 vaccine

Reuters
Updated ·1 min read
FILE PHOTO: People pose with syringe with needle in front of displayed Moderna logo

(Reuters) -Moderna Inc said on Monday it expected to record sales of about $18.5 billion in 2022 from contracts for its COVID-19 vaccine, and about $3.5 billion from potential additional purchases including booster candidates updated for variants.

The company in November said its sales could be in the range of $17 billion to $22 billion in 2022.

Moderna said it was in active discussions for additional COVID-19 vaccine contracts this year.

The company also said it was developing a booster vaccine candidate, called mRNA-1273.529, that targets the fast-spreading Omicron variant and expects it to advance into clinical trials in early 2022.

ADVERTISEMENT

Booster doses of the company's current COVID-19 vaccine, mRNA-1273, increased neutralizing antibody levels against Omicron at both 50 microgram and 100 microgram dose levels, the drugmaker said.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)